Severe mitral regurgitation, an unusual manifestation of chemotherapy-induced cardiotoxicity

被引:1
|
作者
Mirdamadi, Ahmad [1 ]
Naeini, Afsoon Emami [2 ]
Behjati, Mohaddeseh [3 ]
机构
[1] Islamic Azad Univ, Najafabad Branch, Dept Cardiol, Esfahan, Iran
[2] Isfahan Univ Med Sci, Isfahan Kidney Dis Res Ctr, Dept Nephrol, Esfahan, Iran
[3] Isfahan Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Tehran, Iran
关键词
Cardiotoxicity; chemotherapy; mitral regurgitation;
D O I
10.4103/jrms.JRMS_471_17
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiotoxicity is one of the most feared side effects of chemotherapy with enhanced morbidity and mortality in survivors. Arrhythmia, heart failure, myocardial ischemia, hypertension, and thromboembolism are commonly reported as side effects. Hereby, we are reporting a case of severe mitral regurgitation as a complication of chemotherapy.
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Biomarkers in early detection of anthracycline chemotherapy-induced cardiotoxicity
    Luo, Fanyan
    Bu, Haisong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 345 : 118 - 118
  • [42] Unusual insertion of a mitral chord causing severe valve regurgitation
    Taglieri, Corrado
    Botta, Luca
    Roghi, Alberto
    Alberti, Antonia
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2010, 38 (03) : 387 - 387
  • [43] Unusual ethiologies of severe acute mitral regurgitation not requiring surgery
    Foroughi, Mahnoosh
    Hassantash, Seyed-Ahmad
    Saadat, Habib
    Ghanavaty, Arash
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2008, 34 (04) : 925 - 925
  • [44] Guarding the heart: How SGLT-2 inhibitors protect against chemotherapy-induced cardiotoxicity SGLT-2 inhibitors and chemotherapy-induced cardiotoxicity
    Vafa, Reza Golchin
    Sabahizadeh, Amirreza
    Mofarrah, Ramina
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (03)
  • [45] Wearable cardioverter defibrillator use in patients with chemotherapy-induced cardiotoxicity
    Bianco, N.
    Szymkiewicz, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S324 - S324
  • [46] CHEMOTHERAPY-INDUCED CARDIOTOXICITY IN ONCOLOGY DRUGS INVOLVED AND CLINICAL ASSESSMENT
    Cainap, Simona Sorana
    Nagy, Viorica
    Cainap, Calin
    FARMACIA, 2016, 64 (04) : 487 - 492
  • [47] Biomarkers in the early detection of chemotherapy-induced cardiotoxicity; current state
    Jimenez Cotes, Evert Armando
    Meyer Martinez, Wendy Sofia
    Gallego Gonzalez, Daniel
    ARCHIVOS DE MEDICINA, 2015, 15 (01): : 126 - 137
  • [48] MKP-5 Deficiency Attenuates Chemotherapy-Induced Cardiotoxicity
    Gaytan, Samantha L.
    Perales, Jaime
    Rojas, Aixa
    Gutierrez, Jaime
    Melendez, Celeste
    Min, Kisuk
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2023, 55 (09) : 643 - 643
  • [49] Early detection of chemotherapy-induced cardiotoxicity in breast cancer patients
    Salvador-Coloma, Carmen
    Hernandiz, Amparo
    Tejedor, Sandra
    Miro, Vicente
    Palomar, Laura
    Salvador, Antonio
    Sepulveda, Pilar
    Santaballa, Ana
    CANCER RESEARCH, 2018, 78 (04)
  • [50] A Rationally Designed Cardioprotective Nanoparticle to Treat Chemotherapy-Induced Cardiotoxicity
    Khatun, Zehedina
    Kung, Andrew
    Boukhalfa, Asma
    Thompson, Anna-Lee
    Weng, Sydney
    Wei, Lan
    Meng, Lin
    Martin, Gregory
    Mekkaoui, Choukri
    Blanton, Robert
    Baleja, James
    Yang, Vicky
    Yuan, Hushan
    Chen, Howard
    CIRCULATION, 2024, 150